COVID vaccine: BioNTech faces patent lawsuit in Germany over use of MRNA technology Ruchika Sharma6 July 2022 5:00 PM ISTCureVac said that it was not seeking an injunction, nor intended to take legal action that would impede the production, sale or distribution of the...
BioNTech in conflict with regulator over new COVID vaccine nod: WAS newspaper Ruchika Sharma25 Jun 2022 1:30 PM ISTThe reason for this was that the approval "should go through the same regulatory process as ordinary flu vaccines", which would allow the new COVID-19...
Pfizer-BioNTech COVID vaccines effective, safe for children aged 6 months to 4 years: USFDA staff Ruchika Sharma13 Jun 2022 1:45 PM ISTAn early analysis of data from Pfizer-BioNTech's vaccine based on 10 symptomatic COVID-19 cases identified when the Omicron coronavirus variant was...
Africa to get BioNTech mRNA vaccine factory soon Ruchika Sharma12 Jun 2022 9:00 AM ISTBioNTech has said the BioNTainers could make other mRNA vaccines against malaria or tuberculosis, depending on product development progress and future...
Pfizer-BioNTech COVID booster authorized in Canada for 16, 17-year-olds Ruchika Sharma2 Jun 2022 10:00 AM ISTThe agency said potential risks of inflammatory heart conditions, myocarditis or pericarditis, have been included in the shot's label.
Pfizer-BioNTech COVID booster shot gets USFDA emergency use nod for children aged 5 to 11 Ruchika Sharma18 May 2022 11:48 AM ISTThe Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech’s proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Health Bulletin 17/May/2022 Isra Zaman17 May 2022 4:40 PM ISTHere are the top health stories for the day: Entry level Ayush NABH certificates given to 5 Ayurveda Hospitals Ministry of Ayush has...
USFDA to soon authorize Pfizer COVID booster shot for children aged 5 to 11: NYT Ruchika Sharma17 May 2022 11:00 AM ISTThey have cited data from a mid- to late-stage study showing a third dose of their shot increased protection against the original coronavirus version...
BioNTech posts tripled Q1 vaccine sales but still flags full-year decline Ruchika Sharma10 May 2022 9:15 AM ISTBioNTech reiterated its 2022 vaccine revenue guidance of between 13 billion and 17 billion euros, down from 19 billion last year, implying a decline...
Pfizer gets expanded USFDA emergency use nod for additional COVID Vaccine booster in adults aged 50 years and older Ruchika Sharma30 March 2022 12:25 PM ISTThe additional booster is to be administered at least four months after the first booster and is the same formulation and strength as prior...
BioNTech- Pfizer Omicron vaccine delayed, says BioNTech Chief Ugur Sahin Ruchika Sharma17 Feb 2022 3:25 PM ISTBerlin: Delivery of Pfizer and BioNTech SE's vaccine to combat the Omicron COVID-19 variant was delayed by several weeks due to a slower-than...
Confident of quickly adapting vaccine for Omicron: BioNTech CEO Ruchika Sharma5 Dec 2021 11:00 AM ISTFrankfurt: Germany's BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the Omicron variant, its CEO Ugur...
